Arovella Therapeutics: Why is everyone talking “immunotherapy” for cancer? 

Listen to ASX-listed Arovella Therapeutics Managing Director Dr Michael Baker talk to Matt Birney on the Bulls N’ Bears Report about Arovella’s amazing technology that can temporarily remove blood cells from the body and reprogram them to seek and destroy cancer cells before being reinserted.

Arovella Therapeutics: Why is everyone talking &ldquo;immunotherapy&rdquo; for cancer? 
Listen to ASX-listed Arovella Therapeutics Managing Director Dr Michael Baker talk to Matt Birney on the Bulls N&rsquo; Bears Report about Arovella&rsquo;s amazing technology that can temporarily remove blood cells from the body and reprogram them to seek and destroy cancer cells before being reinserted.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement